NanJing Pharmaceutical Company Limited reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 44,964.11 million compared to CNY 39,700.21 million a year ago. Revenue was CNY 45,123.2 million compared to CNY 39,817.36 million a year ago.

Net income was CNY 505.18 million compared to CNY 376.41 million a year ago. Basic earnings per share from continuing operations was CNY 0.485 compared to CNY 0.361 a year ago. Diluted earnings per share from continuing operations was CNY 0.485 compared to CNY 0.361 a year ago.